Neurovalens
Neurovalens develops non-invasive neurostimulation medical devices to address global health challenges.
Filter & sort
Recently funded companies in the UK tech ecosystem.
Neurovalens develops non-invasive neurostimulation medical devices to address global health challenges.

Owlstone Medical provides breath biopsy technology for early disease detection and precision medicine.
Oxford Cancer Analytics develops blood tests for early cancer detection using proteomics and artificial intelligence.
Oxford Endovascular develops origami engineered medical devices to prevent brain haemorrhage.
PD Neurotechnology builds wearable medical devices for monitoring Parkinson disease.

Perspectum builds medical imaging software that uses artificial intelligence to improve the diagnosis of chronic diseases and cancer.
Pill Connect builds digital tracking devices to monitor medication adherence in clinical trials.